Federal award (DELIVERY ORDER, fiscal year 2021)
Recipient: UNIVERSITY OF WISCONSIN SYSTEM
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2015-07-01 to 2022-08-31
Current total value of award: $1214304.57
Description: A PHASE I TRIAL OF THE SAFETY AND IMMUNOGENICITY OF A DNA PLASMID BASED VACCINE (WOKVAC) ENCODING EPITOPES DERIVED FROM THREE BREAST CANCER ANTIGENS (IGFBP-2, HER2, AND IGF-IR) IN PATIENTS WITH BREAST CANCER